Abdalla Ayah Isam, Elazrag Amna Mutasim, Mohammed Siralkhatim, Hassan Hassan
Faculty of Medicine, University of Khartoum, Khartoum, Sudan.
Int J Gen Med. 2024 Jun 24;17:2847-2853. doi: 10.2147/IJGM.S463352. eCollection 2024.
COVID-19, a highly infectious virus, poses significant risks, particularly for immuno-compromised individuals. Vaccination remains a key preventive measure, yet acceptance rates vary among populations globally.
This study aims to assess COVID-19 vaccine acceptance and hesitancy among dialysis patients atDr. Salma Center for Dialysis in 2022, highlighting the primary reasons for hesitancy within this vulnerable group.
A descriptive cross-sectional study was conducted at Dr. Salma Center in Khartoum, Sudan, in 2022. A systematic random sampling method was employed to select participants, who were interviewed using a structured questionnaire.
Of a sample of 137 patients, 125 completed the questionnaire with 91.2% response rate. Approximately half of the respondents reported vaccine hesitancy 50%, with 77% acknowledging the severity of COVID-19 but only 53% advised vaccination among their peers. Primary concerns included vaccine side effects 24.8% and mistrust of production companies 10.4%. No significant associations were found between vaccine hesitancy and demographic factors.
The study reveals a notable prevalence of COVID-19 vaccine hesitancy among dialysis patients at Dr. Salma Center in Khartoum, 2022. Addressing this hesitancy requires concerted efforts to bridge the trust gap between patients and healthcare systems, coupled with targeted awareness campaigns to correct misinformation and reinforce confidence in vaccines.
新型冠状病毒肺炎（COVID-19）是一种高传染性病毒，带来重大风险，尤其是对免疫功能低下的个体。接种疫苗仍然是关键的预防措施，但全球不同人群的疫苗接受率各不相同。
本研究旨在评估2022年萨尔玛透析中心透析患者对COVID-19疫苗的接受情况和犹豫程度，突出该弱势群体犹豫的主要原因。
2022年在苏丹喀土穆的萨尔玛中心进行了一项描述性横断面研究。采用系统随机抽样方法选择参与者，使用结构化问卷对他们进行访谈。
在137名患者样本中，125人完成了问卷，回复率为91.2%。约一半的受访者表示对疫苗犹豫（50%），77%的人承认COVID-19的严重性，但只有53%的人建议同龄人接种疫苗。主要担忧包括疫苗副作用（24.8%）和对生产公司的不信任（10.4%）。未发现疫苗犹豫与人口统计学因素之间存在显著关联。
该研究揭示了2022年喀土穆萨尔玛中心透析患者中存在显著比例的COVID-19疫苗犹豫情况。解决这种犹豫需要共同努力弥合患者与医疗系统之间的信任差距，同时开展有针对性的宣传活动，纠正错误信息并增强对疫苗的信心。
